NDC 52343-137
Raloxifene Hydrochloride
Raloxifene Hydrochloride
Raloxifene Hydrochloride is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Acetris Health, Llc. The primary component is Raloxifene Hydrochloride.
| Product ID | 52343-137_d0f0c7e4-9cd5-4939-a619-ec103e800e0f |
| NDC | 52343-137 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Raloxifene Hydrochloride |
| Generic Name | Raloxifene Hydrochloride |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-08-28 |
| Marketing End Date | 2020-05-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA204310 |
| Labeler Name | ACETRIS HEALTH, LLC |
| Substance Name | RALOXIFENE HYDROCHLORIDE |
| Active Ingredient Strength | 60 mg/1 |
| Pharm Classes | Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] |
| NDC Exclude Flag | N |